Perrigo files ANDA for generic Zegerid OTC product
The Perrigo product is a proton pump inhibitor and antacid indicated for the treatment of frequent heartburn. Perrigo has also provided prior notice of this filing to Schering-Plough
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
Erin Ascher will be responsible for leading Omnicare’s human resources function, including designing and implementing strategies in the areas of attracting, retaining, developing and rewarding employees. Before joining